Earkart Limited
Complete IPO details, including price band, financials, subscription status, and key insights.
Participate in the Earkart Limited IPO with full transparency. Review issue details, company fundamentals, and financial performance, and apply securely through Alice Blue.
IPO Snapshot
Key metrics and details at a glance.
Price Band
₹135
Per ShareLot Size
1000 Shares
Minimum Investment
₹1,35,000
Issue Size
₹49.26 Cr
Face Value
₹10
Per ShareIPO Type
Fixed Price - SME
Retail Quota
50%
QIB Quota
0%
NII Quota
50%
IPO Timeline
Important dates for your applying strategy.
Subscription Status
Live demand across investor categories.
Track real-time subscription levels:
*Real-time data subject to exchange updates
Earkart Limited
Business model, operations, and market positioning.
Promoter Holding (Pre-Issue)
78.75%
Promoter Holding (Post-Issue)
57.34%
Issue Type
Fixed Price - SME
ISIN
INE1A8F01035
About the Company
We Manufacture and distribute modern hearing aids and related accessories at affordable price across India. Along with our own manufactured hearing aid, we also trade in hearing aid, parts and accessories of other brands manufactured in India and abroad. In addition, we offer other products like adjustable foldable walkers and Multi-Sensory Integrated Educational Development (MSIED) and Teaching Learning Material (TLM) kits to support mobility and daily needs of physically challenged. Our mission is to make quality hearing care more accessible. We've developed a smart and easy-to-use Remote Audiometry Machine (OMNI) that allows people to get tested and fitted for hearing aids from anywhere in the world. By combining advanced technology with a strong focus on customer needs, we aim to improve hearing care across India.
Industry Overview
Hearing loss occurs when there is a problem in the hearing system and is defined by WHO as the inability to hear sounds below 35 decibels in the better ear. About 80% of people with disabling hearing loss live in low and middleincome countries, and risk increases with age, especially after 60. There are three main types: conductive (outer/middle ear issues), sensorineural (inner ear or nerve damage), and mixed (a combination of both). Causes include infections, injury, noise exposure, and aging. Hearing aids, which amplify sound using a microphone, amplifier, and speaker, help people hear better in various environments.
Company History
Our Company was originally formed as a Private Limited Company in the name and style of "Earkart Private Limited" under the provisions of the Companies Act, 2013 on April 14, 2021 vide Certificate of Incorporation issued by Registrar of Companies, Kanpur bearing CIN: U74999UP2021PTC145093. Subsequently, our Company was converted into a Public Limited Company under the Companies Act, 2013 pursuant to a special resolution passed by the shareholders of our Company on November 27, 2024 and the name was changed to "Earkart Limited" pursuant to a fresh Certificate of Incorporation dated December 18, 2024 issued by the Registrar of Companies, Central Processing Centre, bearing CIN: U74999DL2021PLC399313.
Products & Services
- The Company Manufactures and distributes modern hearing aids and related accessories at affordable price across India.
Growth Strategy
- Geographical Expansion.
- Marketing Initiative.
- Continued Focus on Innovation and Technology.
Customer Base
Wholesaler and Retailer
Financial Performance
Revenue, profit after tax and total assets across the last 3 reported financial years.
Revenue
Amount in ₹ crore
Profit After Tax (PAT)
Amount in ₹ crore
Total Assets
Amount in ₹ crore
Figures in ₹ crore, on a standalone basis, as reported for FY23 to FY25.
Objects of the Issue
How the company plans to utilize IPO proceeds.
Use of Proceeds
The funds raised through this IPO will be used for:
Initial public offering up to 36,49,000 equity shares of Rs. 10 each ("Equity Shares") of Earkart limited (the "Company") for cash at a price of Rs. [*] per equity share (the "Issue Price"), aggregating Rs. [*] Crore ("Offer"). the offer comprises a fresh issue of 33,15,000 equity shares aggregating Rs. [*] Crore ("Fresh Issue") and an offer for sale of 3,34,000 equity shares ("Offered Shares") aggregating Rs. [*] Crore, by Rohit Misra (Selling Shareholder), the ("Offer for Sale"). out of which [*] equity shares of face value of Rs. 10/- each for a cash price of Rs. [*] per equity share, aggregating to Rs. [*] Crore will be reserved for subscription by market maker ("Market Maker Reservation Portion"). the offer less the market maker reservation portion i.e. issue of [*] equity shares of face value of Rs. 10 each at an issue price of Rs. [*] /- per equity share aggregating to Rs. [*] Crore (is Hereinafter Referred to as the "Net Issue"). the issue and the net issue will constitute 26.53 % and [*] %, respectively of the post issue paid up equity share capital of the company. Price Band: Rs. 135/- for equity share of face value of Rs. 10 each. The floor price is 13.5 times times the face value of the face value of the equity shares. Bids can made for a minimum of 2000 equity shares and in multiples of 1000 equity shares thereafter.
*Subject to approvals and market conditions.
Strengths & Risks
Key competitive advantages and factors to consider before investing.
- We have diversified client base ranging from government, to, clinics, retailers and doctors.
- Established and proven track record.
- Leveraging the experience of our Promoter.
- Experienced management team and a motivated Employees.
- Cordial relations with our client.
- Our revenue from sale of products derived from government institutions accounted for 69.32%, 75.85% and 86.56% for the Fiscal 2025, Fiscal 2024 and Fiscal 2023 respectively. A failure to secure similar government contracts or orders in the future could adversely impact our business, operating results, and financial condition.
- We are subject to complex laws and governmental regulations governing our products and our business operations, compliance with these laws and regulations requires time and cost, and any adverse regulatory action may adversely affect our financial condition, cash flows and business operations.
- We face risks relating to sourcing of raw materials and components for manufacturing of our hearing aids and related devices from third parties.
- Our Manufacturing Facility is located in Noida, Uttar Pradesh. Any disruption, breakdown or shutdown of our Manufacturing may have a material adverse effect on our business, financial condition, results of operations and cash flow.
- Loss of any of our key customers or reduction in demand from our customers may materially and adversely affect our business and financial performance.